Trends in Perinatal HIV Prevention in New York City, 1994–2003
Authors:
- 1 October 2008
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 98 (10) , 1857-1864
Abstract
Objectives. We examined trends in perinatal HIV prevention interventions in New York City implemented during 1994 to 2003 to ascertain the success of the interventions in reducing perinatal transmission. Methods. We used data obtained from infant records at 22 hospitals. We used multiple logistic regression to analyze factors associated with prenatal care and perinatal HIV transmission. Results. We analyzed data for 4729 perinatally HIV-exposed singleton births. Of mothers with prenatal care data, 92% had prenatal care. The overall proportion who received prenatal care and were diagnosed with HIV before delivery was 86% in 1994 to 1996 and 90% in 1997 to 2003. Use of prenatal antiretrovirals among mothers who received prenatal care was 63% in 1994 to 1996 and 82% in 1997 to 2003. From 1994 to 2003, cesarean births among the entire sample increased from 15% to 55%. During 1997 to 2003, the perinatal HIV transmission rate among the entire sample was 7%; 45% of mothers of infected infants had missed opportunities for perinatal HIV prevention. During 1997 to 2003, maternal illicit drug use was significantly associated with lack of prenatal care. Lack of prenatal, intrapartum, and neonatal antiretrovirals; maternal illicit drug use; and low birthweight were significantly associated with perinatal HIV transmission. Conclusions. Interventions for perinatal HIV prevention can successfully decrease HIV transmission rates. Ongoing perinatal HIV surveillance allows for monitoring the implementation of guidelines to prevent mother-to-child transmission of HIV and determining factors that may contribute to perinatal HIV transmission.Keywords
This publication has 34 references indexed in Scilit:
- ACOG Committee Opinion #304: Prenatal and Perinatal Human Immunodeficiency Virus Testing: Expanded RecommendationsObstetrics & Gynecology, 2004
- Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in ThailandNew England Journal of Medicine, 2004
- Human Milk, Breastfeeding, and Transmission of Human Immunodeficiency Virus Type 1 in the United StatesPediatrics, 2003
- Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North CarolinaThe Pediatric Infectious Disease Journal, 2002
- Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trialThe Lancet, 2002
- Perinatal Transmission of Human Immunodeficiency Virus Type 1 by Pregnant Women with RNA Virus Loads <1000 Copies/mLThe Journal of Infectious Diseases, 2001
- A Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1New England Journal of Medicine, 2000
- 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trialThe Lancet, 1999
- Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, ThailandAIDS, 1999
- HIV Infection in Heterosexual Female Intravenous Drug Users in New York City, 1977–1980New England Journal of Medicine, 1988